| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.30e-06 | 188 | 106 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.09e-05 | 12 | 106 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 5.07e-05 | 14 | 106 | 3 | GO:0097493 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | ICOSLG APLF IGLV3-25 IGLV1-51 FBN1 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV2-28 | 5.60e-07 | 241 | 108 | 10 | GO:0002377 |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 7.58e-06 | 8 | 109 | 3 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 7.58e-06 | 8 | 109 | 3 | GO:0071756 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 1.13e-05 | 9 | 109 | 3 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 1.61e-05 | 10 | 109 | 3 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 1.61e-05 | 10 | 109 | 3 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 1.61e-05 | 10 | 109 | 3 | GO:0071751 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV3-25 IGLV1-51 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV2-28 | 2.65e-05 | 166 | 109 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | EMILIN complex | 2.69e-05 | 2 | 109 | 2 | GO:1990971 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 5.99e-05 | 15 | 109 | 3 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 5.99e-05 | 15 | 109 | 3 | GO:0071753 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 8.89e-05 | 17 | 109 | 3 | GO:0042571 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 8.89e-05 | 17 | 109 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.47e-04 | 96 | 109 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | keratohyalin granule | 2.67e-04 | 5 | 109 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN VTN CELA2A EMILIN2 PAPLN CELA2B EMILIN1 FBN1 MUC17 DMBT1 | 4.56e-04 | 530 | 109 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | ATPase complex | 5.79e-04 | 129 | 109 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | extracellular matrix | RELN VTN CELA2A EMILIN2 PAPLN CRISP3 CELA2B EMILIN1 FBN1 MUC17 DMBT1 | 6.33e-04 | 656 | 109 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | RELN VTN CELA2A EMILIN2 PAPLN CRISP3 CELA2B EMILIN1 FBN1 MUC17 DMBT1 | 6.49e-04 | 658 | 109 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | ISWI-type complex | 2.35e-03 | 14 | 109 | 2 | GO:0031010 | |
| MousePheno | abnormal blood coagulation | 6.52e-06 | 240 | 77 | 9 | MP:0002551 | |
| MousePheno | abnormal hemostasis | 6.97e-06 | 242 | 77 | 9 | MP:0009676 | |
| Domain | CUB | 5.17e-12 | 49 | 102 | 9 | PF00431 | |
| Domain | CUB | 6.28e-12 | 50 | 102 | 9 | SM00042 | |
| Domain | - | 9.13e-12 | 52 | 102 | 9 | 2.60.120.290 | |
| Domain | CUB | 1.10e-11 | 53 | 102 | 9 | PS01180 | |
| Domain | CUB_dom | 2.18e-11 | 57 | 102 | 9 | IPR000859 | |
| Domain | Sushi | 9.33e-06 | 52 | 102 | 5 | PF00084 | |
| Domain | CCP | 1.13e-05 | 54 | 102 | 5 | SM00032 | |
| Domain | SUSHI | 1.35e-05 | 56 | 102 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.47e-05 | 57 | 102 | 5 | IPR000436 | |
| Domain | MAM | 1.02e-04 | 17 | 102 | 3 | SM00137 | |
| Domain | MAM | 1.22e-04 | 18 | 102 | 3 | PF00629 | |
| Domain | MAM_dom | 1.22e-04 | 18 | 102 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.22e-04 | 18 | 102 | 3 | PS50060 | |
| Domain | EGF | 3.06e-04 | 235 | 102 | 7 | SM00181 | |
| Domain | EGF_3 | 3.06e-04 | 235 | 102 | 7 | PS50026 | |
| Domain | Bromodomain_CS | 3.75e-04 | 26 | 102 | 3 | IPR018359 | |
| Domain | EGF-like_dom | 4.33e-04 | 249 | 102 | 7 | IPR000742 | |
| Domain | EGF_1 | 5.00e-04 | 255 | 102 | 7 | PS00022 | |
| Domain | EGF-like_CS | 5.74e-04 | 261 | 102 | 7 | IPR013032 | |
| Domain | EGF_2 | 6.28e-04 | 265 | 102 | 7 | PS01186 | |
| Domain | PHD | 7.57e-04 | 75 | 102 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 9.20e-04 | 79 | 102 | 4 | IPR019787 | |
| Domain | BROMODOMAIN_1 | 1.07e-03 | 37 | 102 | 3 | PS00633 | |
| Domain | Bromodomain | 1.16e-03 | 38 | 102 | 3 | PF00439 | |
| Domain | Allrgn_V5/Tpx1_CS | 1.29e-03 | 10 | 102 | 2 | IPR018244 | |
| Domain | EMI | 1.29e-03 | 10 | 102 | 2 | PF07546 | |
| Domain | PHD | 1.43e-03 | 89 | 102 | 4 | SM00249 | |
| Domain | BROMODOMAIN_2 | 1.45e-03 | 41 | 102 | 3 | PS50014 | |
| Domain | Bromodomain | 1.56e-03 | 42 | 102 | 3 | IPR001487 | |
| Domain | BROMO | 1.56e-03 | 42 | 102 | 3 | SM00297 | |
| Domain | - | 1.56e-03 | 42 | 102 | 3 | 1.20.920.10 | |
| Domain | Znf_PHD | 1.56e-03 | 91 | 102 | 4 | IPR001965 | |
| Domain | CRISP_1 | 1.57e-03 | 11 | 102 | 2 | PS01009 | |
| Domain | CRISP_2 | 1.57e-03 | 11 | 102 | 2 | PS01010 | |
| Domain | ZF_PHD_2 | 1.82e-03 | 95 | 102 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.90e-03 | 96 | 102 | 4 | PS01359 | |
| Domain | IG | 2.16e-03 | 421 | 102 | 8 | SM00409 | |
| Domain | Ig_sub | 2.16e-03 | 421 | 102 | 8 | IPR003599 | |
| Domain | CAP | 2.96e-03 | 15 | 102 | 2 | PF00188 | |
| Domain | SCP | 2.96e-03 | 15 | 102 | 2 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.96e-03 | 15 | 102 | 2 | IPR001283 | |
| Domain | - | 2.96e-03 | 15 | 102 | 2 | 3.40.33.10 | |
| Domain | CAP_domain | 2.96e-03 | 15 | 102 | 2 | IPR014044 | |
| Domain | EMI_domain | 3.37e-03 | 16 | 102 | 2 | IPR011489 | |
| Domain | MAM_1 | 3.37e-03 | 16 | 102 | 2 | PS00740 | |
| Domain | Laminin_N | 3.37e-03 | 16 | 102 | 2 | IPR008211 | |
| Domain | AT_hook | 3.37e-03 | 16 | 102 | 2 | PF02178 | |
| Domain | LamNT | 3.37e-03 | 16 | 102 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 3.37e-03 | 16 | 102 | 2 | PS51117 | |
| Domain | Laminin_N | 3.37e-03 | 16 | 102 | 2 | PF00055 | |
| Domain | EMI | 3.81e-03 | 17 | 102 | 2 | PS51041 | |
| Domain | KU | 4.27e-03 | 18 | 102 | 2 | SM00131 | |
| Domain | - | 4.27e-03 | 18 | 102 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 4.27e-03 | 18 | 102 | 2 | IPR020901 | |
| Domain | - | 4.50e-03 | 122 | 102 | 4 | 3.40.30.10 | |
| Domain | BPTI_KUNITZ_1 | 4.75e-03 | 19 | 102 | 2 | PS00280 | |
| Domain | BPTI_KUNITZ_2 | 4.75e-03 | 19 | 102 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 4.75e-03 | 19 | 102 | 2 | PF00014 | |
| Domain | TSP_1 | 4.95e-03 | 63 | 102 | 3 | PF00090 | |
| Domain | TSP1 | 5.41e-03 | 65 | 102 | 3 | SM00209 | |
| Domain | TSP1_rpt | 5.41e-03 | 65 | 102 | 3 | IPR000884 | |
| Domain | TSP1 | 5.41e-03 | 65 | 102 | 3 | PS50092 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | VTN IGLV3-25 CFHR4 IGLV1-51 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 3.99e-07 | 115 | 84 | 8 | M19752 |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.60e-06 | 61 | 84 | 6 | M27581 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.32e-06 | 69 | 84 | 6 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 3.32e-06 | 69 | 84 | 6 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 3.93e-06 | 71 | 84 | 6 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 3.93e-06 | 71 | 84 | 6 | M27203 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 7.89e-06 | 80 | 84 | 6 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 9.11e-06 | 82 | 84 | 6 | M27110 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.20e-05 | 86 | 84 | 6 | M27206 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.20e-05 | 86 | 84 | 6 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.28e-05 | 87 | 84 | 6 | M27205 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 2.13e-05 | 95 | 84 | 6 | M29842 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.54e-05 | 98 | 84 | 6 | M27152 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.71e-05 | 32 | 84 | 4 | MM14854 | |
| Pathway | REACTOME_PARASITE_INFECTION | 6.57e-05 | 116 | 84 | 6 | M29843 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.67e-05 | 37 | 84 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.23e-05 | 39 | 84 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.33e-04 | 44 | 84 | 4 | M26969 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.46e-04 | 134 | 84 | 6 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 1.58e-04 | 136 | 84 | 6 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.08e-04 | 143 | 84 | 6 | M27107 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 3.11e-04 | 154 | 84 | 6 | M39007 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 4.64e-04 | 166 | 84 | 6 | M608 | |
| Pathway | BIOCARTA_PEPI_PATHWAY | 7.23e-04 | 7 | 84 | 2 | MM1589 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 8.44e-04 | 186 | 84 | 6 | M27175 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 9.42e-04 | 190 | 84 | 6 | M8240 | |
| Pathway | BIOCARTA_PEPI_PATHWAY | 9.60e-04 | 8 | 84 | 2 | M22084 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.05e-03 | 194 | 84 | 6 | M16312 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.58e-03 | 84 | 84 | 4 | MM14653 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.95e-03 | 219 | 84 | 6 | M29836 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | MGAM VTN ATG7 CRISP3 IGLV3-25 CFHR4 IGLV1-51 ATP11B MUC17 AGA AGL IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 2.51e-03 | 1128 | 84 | 15 | M1036 |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 12906867 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 98179 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 99744 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 4691517 | ||
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 9603450 | ||
| Pubmed | Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development. | 1.18e-06 | 166 | 112 | 7 | 19906978 | |
| Pubmed | 1.68e-06 | 175 | 112 | 7 | 28071719 | ||
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 1.80e-06 | 8 | 112 | 3 | 32948785 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ICOSLG MGAM FAT4 VTN GPRC5C TSG101 CUBN SLC44A4 PI15 GSTT2B GSTT2 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 | 1.84e-06 | 1070 | 112 | 15 | 23533145 |
| Pubmed | Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains. | 1.03e-05 | 2 | 112 | 2 | 25445627 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12833571 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 3100621 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9854036 | ||
| Pubmed | Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo. | 1.03e-05 | 2 | 112 | 2 | 26156437 | |
| Pubmed | Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. | 1.03e-05 | 2 | 112 | 2 | 12659673 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28386233 | ||
| Pubmed | Structural and affinity studies of IgM polyreactive natural autoantibodies. | 1.03e-05 | 2 | 112 | 2 | 8993018 | |
| Pubmed | Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans. | 1.03e-05 | 2 | 112 | 2 | 16327289 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18434520 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26746425 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2263605 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15522311 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22483866 | ||
| Pubmed | Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. | 1.03e-05 | 2 | 112 | 2 | 11906208 | |
| Pubmed | Human netrin-G1 isoforms show evidence of differential expression. | 1.03e-05 | 2 | 112 | 2 | 15901489 | |
| Pubmed | EMILIN2 regulates platelet activation, thrombus formation, and clot retraction. | 1.03e-05 | 2 | 112 | 2 | 25658937 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22566882 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17507910 | ||
| Pubmed | Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors. | 1.03e-05 | 2 | 112 | 2 | 25068647 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 1936125 | ||
| Pubmed | Identification and characterization of GSTT3, a third murine Theta class glutathione transferase. | 1.03e-05 | 2 | 112 | 2 | 12038961 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21143350 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15219549 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.03e-05 | 2 | 112 | 2 | 27890662 | |
| Pubmed | Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody. | 1.03e-05 | 2 | 112 | 2 | 6404298 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19424424 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 3646943 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.03e-05 | 2 | 112 | 2 | 21439553 | |
| Pubmed | Mammalian class theta GST and differential susceptibility to carcinogens: a review. | 1.03e-05 | 2 | 112 | 2 | 11018744 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8617493 | ||
| Pubmed | Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16. | 1.03e-05 | 2 | 112 | 2 | 2110659 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.03e-05 | 2 | 112 | 2 | 24408017 | |
| Pubmed | Netrin-G2 dysfunction causes a Rett-like phenotype with areflexia. | 1.03e-05 | 2 | 112 | 2 | 31692205 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11278945 | ||
| Pubmed | Implication of neuropilin 2/semaphorin 3F in retinocollicular map formation. | 1.03e-05 | 2 | 112 | 2 | 18942144 | |
| Pubmed | Identification of disease-specific genes in chronic pancreatitis using DNA array technology. | 1.03e-05 | 2 | 112 | 2 | 11729383 | |
| Pubmed | What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome? | 1.03e-05 | 2 | 112 | 2 | 23369858 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15705354 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 1417752 | ||
| Pubmed | An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. | 1.03e-05 | 2 | 112 | 2 | 18369450 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19790074 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7789971 | ||
| Pubmed | 1.12e-05 | 90 | 112 | 5 | 15033168 | ||
| Pubmed | Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System. | 1.44e-05 | 15 | 112 | 3 | 27667971 | |
| Pubmed | 1.76e-05 | 167 | 112 | 6 | 22159717 | ||
| Pubmed | 2.06e-05 | 102 | 112 | 5 | 10231032 | ||
| Pubmed | 2.14e-05 | 17 | 112 | 3 | 8223863 | ||
| Pubmed | DOT1L deletion impairs the development of cortical parvalbumin-expressing interneurons. | 2.45e-05 | 52 | 112 | 4 | 37566909 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 21273439 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 21610314 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 23028371 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 12845630 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17595163 | ||
| Pubmed | Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency. | 3.08e-05 | 3 | 112 | 2 | 27751443 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 8761485 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17388942 | ||
| Pubmed | Secreted semaphorins modulate synaptic transmission in the adult hippocampus. | 3.08e-05 | 3 | 112 | 2 | 15814792 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 39138514 | ||
| Pubmed | TEX15 associates with MILI and silences transposable elements in male germ cells. | 3.08e-05 | 3 | 112 | 2 | 32381626 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17443771 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 25201528 | ||
| Pubmed | Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA. | 3.08e-05 | 3 | 112 | 2 | 3427074 | |
| Pubmed | Genome-wide association study of serum selenium concentrations. | 3.08e-05 | 3 | 112 | 2 | 23698163 | |
| Pubmed | EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro. | 3.08e-05 | 3 | 112 | 2 | 17988845 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 30783009 | ||
| Pubmed | Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. | 3.08e-05 | 3 | 112 | 2 | 9883722 | |
| Pubmed | Immunoglobulin genes of different subgroups are interdigitated within the VK locus. | 3.08e-05 | 3 | 112 | 2 | 6440122 | |
| Pubmed | Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling. | 3.08e-05 | 3 | 112 | 2 | 25143608 | |
| Pubmed | 3.98e-05 | 117 | 112 | 5 | 17145500 | ||
| Pubmed | 5.67e-05 | 126 | 112 | 5 | 16284245 | ||
| Pubmed | Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. | 6.14e-05 | 4 | 112 | 2 | 10707970 | |
| Pubmed | Identification of transcriptional regulatory elements for Ntng1 and Ntng2 genes in mice. | 6.14e-05 | 4 | 112 | 2 | 24642214 | |
| Pubmed | Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation. | 6.14e-05 | 4 | 112 | 2 | 21924961 | |
| Pubmed | Identification, characterization, and crystal structure of the Omega class glutathione transferases. | 6.14e-05 | 4 | 112 | 2 | 10783391 | |
| Pubmed | Structural basis for cell surface patterning through NetrinG-NGL interactions. | 6.14e-05 | 4 | 112 | 2 | 21946559 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 12890759 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 29154130 | ||
| Pubmed | Emilin1 links TGF-beta maturation to blood pressure homeostasis. | 6.14e-05 | 4 | 112 | 2 | 16530041 | |
| Pubmed | Netrin-G/NGL complexes encode functional synaptic diversification. | 6.14e-05 | 4 | 112 | 2 | 25411505 | |
| Pubmed | Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments. | 6.14e-05 | 4 | 112 | 2 | 17785411 | |
| Pubmed | TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing. | 6.14e-05 | 4 | 112 | 2 | 32719317 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 17023586 | ||
| Pubmed | Complementary expression and neurite outgrowth activity of netrin-G subfamily members. | 6.14e-05 | 4 | 112 | 2 | 11804778 | |
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 7.10e-05 | 25 | 112 | 3 | 38355799 | |
| Pubmed | Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. | 1.02e-04 | 5 | 112 | 2 | 14516677 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 9729470 | ||
| Pubmed | Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. | 1.02e-04 | 5 | 112 | 2 | 16202709 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 23902858 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 8468048 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 9331348 | ||
| Cytoband | 2p12 | 4.62e-07 | 117 | 112 | 6 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 1.48e-05 | 213 | 112 | 6 | chr2p11 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.66e-06 | 83 | 79 | 6 | 351 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.91e-06 | 57 | 79 | 5 | 1179 | |
| GeneFamily | Netrins | 2.80e-04 | 6 | 79 | 2 | 661 | |
| GeneFamily | EMI domain containing | 3.90e-04 | 7 | 79 | 2 | 540 | |
| GeneFamily | PHD finger proteins | 6.49e-04 | 90 | 79 | 4 | 88 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.75e-03 | 21 | 79 | 2 | 813 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.32e-09 | 191 | 110 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.07e-08 | 196 | 110 | 10 | M3008 | |
| Coexpression | NABA_MATRISOME | SEMA3F CPAMD8 RELN VTN CELA2A EMILIN2 NTNG1 CDCP2 PAPLN CELA2B EMILIN1 ST14 F13B NTNG2 FBN1 MUC17 FGFBP2 WFIKKN2 DMBT1 | 5.12e-08 | 1026 | 110 | 19 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 2.16e-07 | 270 | 110 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.56e-07 | 275 | 110 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME | SEMA3F RELN VTN CELA2A EMILIN2 NTNG1 CDCP2 PAPLN CELA2B EMILIN1 ST14 F13B NTNG2 FBN1 MUC17 WFIKKN2 DMBT1 | 1.03e-06 | 1008 | 110 | 17 | MM17056 |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN | 3.87e-05 | 16 | 110 | 3 | M41742 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP | 6.21e-05 | 99 | 110 | 5 | M3238 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 7.02e-05 | 325 | 110 | 8 | M39053 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | MGAM STARD10 PAPLN ZNF395 CUBN ABCA8 GSTT2B F13B CFHR4 GSTT2 | 8.73e-05 | 535 | 110 | 10 | MM3635 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | IGLV3-25 IGLV1-51 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 3.49e-06 | 126 | 107 | 7 | Arv_SC-HD_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 4.11e-06 | 183 | 107 | 8 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 4.11e-06 | 183 | 107 | 8 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | IGLV3-25 IGLV1-51 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 6.69e-06 | 139 | 107 | 7 | Arv_SC_fibroblast_500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | IGLV1-51 MUC17 IGKV3D-11 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 3.32e-05 | 244 | 107 | 8 | Arv_SC-H9hpx_1000_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | SLC44A4 MUC17 IGKV3D-11 IGKV2D-28 DMBT1 IGKV3-20 IGKV3-11 IGKV2-28 | 6.10e-05 | 266 | 107 | 8 | Arv_SC-hpx_blastocyst_1000_K2 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | NXPE4 TXNDC11 IGLV3-25 IGLV1-51 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 1.96e-08 | 181 | 112 | 8 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NXPE4 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 2.13e-08 | 183 | 112 | 8 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 184 | 112 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 184 | 112 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 184 | 112 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 2.32e-08 | 185 | 112 | 8 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 2.32e-08 | 185 | 112 | 8 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.49e-08 | 195 | 112 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.49e-08 | 195 | 112 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-51 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 2.84e-07 | 173 | 112 | 7 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGLV3-25 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 3.07e-07 | 175 | 112 | 7 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TXNDC11 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 3.57e-07 | 179 | 112 | 7 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TXNDC11 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 3.57e-07 | 179 | 112 | 7 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-07 | 181 | 112 | 7 | e47664a264a2c37390d1668ce04eef2e0172f4cb | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | EMILIN1 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 4.00e-07 | 182 | 112 | 7 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 4.15e-07 | 183 | 112 | 7 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 4.47e-07 | 185 | 112 | 7 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 4.47e-07 | 185 | 112 | 7 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | TXNDC11 IGKV3D-11 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV3-11 IGKV2-28 | 4.63e-07 | 186 | 112 | 7 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | TXNDC11 IGLV1-51 IGKV3D-11 IGKV3D-7 IGKV3-20 IGKV3-11 IGKV2-28 | 4.98e-07 | 188 | 112 | 7 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 5.34e-07 | 190 | 112 | 7 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 5.34e-07 | 190 | 112 | 7 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV3-25 IGLV1-51 IGKV3D-11 IGKV3D-7 IGKV3-20 IGKV3-11 IGKV2-28 | 6.15e-07 | 194 | 112 | 7 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 6.58e-07 | 196 | 112 | 7 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | TXNDC11 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 6.58e-07 | 196 | 112 | 7 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | NXPE4 IGLV3-25 IGLV1-51 IGKV3D-11 IGKV2D-28 IGKV3-20 IGKV3-11 | 6.58e-07 | 196 | 112 | 7 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.54e-07 | 200 | 112 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.54e-07 | 200 | 112 | 7 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.54e-07 | 200 | 112 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 9.22e-07 | 129 | 112 | 6 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-06 | 139 | 112 | 6 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.62e-06 | 142 | 112 | 6 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 146 | 112 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.11e-06 | 159 | 112 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-06 | 166 | 112 | 6 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-06 | 166 | 112 | 6 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-06 | 167 | 112 | 6 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-06 | 167 | 112 | 6 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 173 | 112 | 6 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.06e-06 | 173 | 112 | 6 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 5.40e-06 | 175 | 112 | 6 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 5.58e-06 | 176 | 112 | 6 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 5.58e-06 | 176 | 112 | 6 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | 5.58e-06 | 176 | 112 | 6 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 177 | 112 | 6 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.77e-06 | 177 | 112 | 6 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.77e-06 | 177 | 112 | 6 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.77e-06 | 177 | 112 | 6 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.77e-06 | 177 | 112 | 6 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.77e-06 | 177 | 112 | 6 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 177 | 112 | 6 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 5.77e-06 | 177 | 112 | 6 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-06 | 178 | 112 | 6 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.15e-06 | 179 | 112 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-06 | 180 | 112 | 6 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-06 | 183 | 112 | 6 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 184 | 112 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-06 | 185 | 112 | 6 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-06 | 185 | 112 | 6 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 7.90e-06 | 187 | 112 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 8.14e-06 | 188 | 112 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.14e-06 | 188 | 112 | 6 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 8.39e-06 | 189 | 112 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.39e-06 | 189 | 112 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.91e-06 | 191 | 112 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 191 | 112 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.91e-06 | 191 | 112 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 191 | 112 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.91e-06 | 191 | 112 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 9.18e-06 | 192 | 112 | 6 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 9.18e-06 | 192 | 112 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 9.18e-06 | 192 | 112 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 9.18e-06 | 192 | 112 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 193 | 112 | 6 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 193 | 112 | 6 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-06 | 194 | 112 | 6 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.74e-06 | 194 | 112 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.74e-06 | 194 | 112 | 6 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.74e-06 | 194 | 112 | 6 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 9.74e-06 | 194 | 112 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.00e-05 | 195 | 112 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | normal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.00e-05 | 195 | 112 | 6 | 7c90d887afde5c4d63352b5171be9987e2dfca58 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-05 | 195 | 112 | 6 | 6095bb237d7bc75cbaeaeb492f6948f3c3fa4848 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 196 | 112 | 6 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.03e-05 | 196 | 112 | 6 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 197 | 112 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-05 | 197 | 112 | 6 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-05 | 197 | 112 | 6 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-05 | 199 | 112 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 112 | 6 | f47bb79202a59404e4916993a1f59cffcf710320 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 6c16151567ef100296f7c12cde350fc6ce146745 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 7da0ccfcd024842ad85f34b523ead6ec61f7e864 | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 112 | 6 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 1.28e-05 | 2 | 106 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | netrin-G1 measurement | 3.83e-05 | 3 | 106 | 2 | EFO_0801825 | |
| Disease | aspartate aminotransferase measurement | SOX6 THSD7A ATG7 STARD10 TNFRSF6B THSD7B CUBN USP8 BAZ2A STK33 CSMD1 MYO15A | 9.99e-05 | 904 | 106 | 12 | EFO_0004736 |
| Disease | Manic Disorder | 1.27e-04 | 71 | 106 | 4 | C0024713 | |
| Disease | Manic | 1.83e-04 | 78 | 106 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 1.92e-04 | 79 | 106 | 4 | C0005587 | |
| Disease | Colorectal Carcinoma | CPAMD8 ERCC6 NTNG1 PTPRU CUBN SLC44A4 CSMD3 ABCA8 PTPRT HIVEP3 | 2.23e-04 | 702 | 106 | 10 | C0009402 |
| Disease | deoxycholate measurement | 3.75e-04 | 39 | 106 | 3 | EFO_0010475 | |
| Disease | asparagine measurement | 4.35e-04 | 41 | 106 | 3 | EFO_0009766 | |
| Disease | interleukin-36 alpha measurement | 4.53e-04 | 9 | 106 | 2 | EFO_0021851 | |
| Disease | alcohol consumption measurement | SEMA3F MGAM RELN THSD7A PAPLN THSD7B CSMD3 BABAM2 STK33 CSMD1 PLCH1 MYO15A FAIM2 | 5.15e-04 | 1242 | 106 | 13 | EFO_0007878 |
| Disease | hydroxyproline measurement | 5.65e-04 | 10 | 106 | 2 | EFO_0010498 | |
| Disease | response to bisphosphonate, osteonecrosis | 5.65e-04 | 10 | 106 | 2 | EFO_0004259, EFO_0009958 | |
| Disease | Tourette syndrome | 7.81e-04 | 50 | 106 | 3 | EFO_0004895 | |
| Disease | 3-formylindole measurement | 9.72e-04 | 13 | 106 | 2 | EFO_0801025 | |
| Disease | alkaline phosphatase measurement | SOX6 NTNG1 PAPLN GPRC5C BABAM2 GSTT2B TXNDC11 CFHR4 HIVEP3 NTNG2 DMBT1 | 1.07e-03 | 1015 | 106 | 11 | EFO_0004533 |
| Disease | complement factor H-related protein 1 measurement | 1.09e-03 | 56 | 106 | 3 | EFO_0600054 | |
| Disease | tea consumption measurement | 1.23e-03 | 129 | 106 | 4 | EFO_0010091 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 1.30e-03 | 15 | 106 | 2 | EFO_0008223 | |
| Disease | opioid dependence | 1.68e-03 | 237 | 106 | 5 | EFO_0005611 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.91e-03 | 68 | 106 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.05e-03 | 364 | 106 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | anorexia nervosa | 2.07e-03 | 70 | 106 | 3 | MONDO_0005351 | |
| Disease | Amphetamine-Related Disorders | 2.52e-03 | 75 | 106 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 2.52e-03 | 75 | 106 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 2.52e-03 | 75 | 106 | 3 | C0236804 | |
| Disease | mucocutaneous lymph node syndrome | 2.62e-03 | 76 | 106 | 3 | EFO_0004246 | |
| Disease | taste liking measurement | 2.81e-03 | 388 | 106 | 6 | EFO_0010155 | |
| Disease | triacylglycerol 58:9 measurement | 2.82e-03 | 22 | 106 | 2 | EFO_0010443 | |
| Disease | sensory peripheral neuropathy, remission | 3.08e-03 | 23 | 106 | 2 | EFO_0009785, MONDO_0002321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLYWICGPQAYRQLP | 416 | Q14264 | |
| CWDRYPNQTLKPSLY | 166 | Q9HA82 | |
| KPNLWCYLNPGDSFS | 76 | Q8IW19 | |
| PGYPEPYGNNLNCIW | 1816 | Q96PZ7 | |
| PGYPAPYEHNLNCIW | 1286 | Q7Z408 | |
| GFPEPYLNSLNCVWK | 1811 | Q7Z408 | |
| DYPEGYGNNLNCIWT | 736 | Q7Z407 | |
| PGYPEFYPNSLNCTW | 1081 | Q7Z407 | |
| SDNNLQYWGLDYPPL | 61 | Q9Y672 | |
| PQYPSSYPNNIRCHW | 271 | Q5VXM1 | |
| ALYVNPLDCYNIHWP | 171 | Q9H981 | |
| CLWNYSQYPSANPGS | 91 | Q9UIF9 | |
| NIKNYGSRPNAPYCW | 896 | Q8IWK6 | |
| APGQIYTYPARCWRK | 66 | Q92782 | |
| INQWYAYRCVPPGDC | 4416 | Q6V0I7 | |
| QECYGVPYIPEGQWL | 241 | Q9ULD4 | |
| AERYWNKSPCYPGEE | 1016 | Q5JWR5 | |
| GTILPNNYPCYVTGW | 146 | P08217 | |
| LWNPSTGQCYKQFDP | 1226 | Q6DHV5 | |
| PYYACPQSFSDWQRP | 1221 | Q9BXF3 | |
| LAYSDPWSCPVGQQL | 546 | Q6VN20 | |
| SGYNAWLSYELQPPA | 601 | Q9UN73 | |
| SYLAWYQQKPGQAPR | 51 | A0A0A0MRZ8 | |
| CLGYICWFQPYQGKN | 771 | P0DP91 | |
| AYWYQQKPGQAPVLV | 51 | P01717 | |
| INCSVYGIPDPQFKW | 66 | O75121 | |
| FCDPVKDYVQANPGW | 126 | Q9BWQ8 | |
| QVPCSYPAHYQFLWG | 191 | Q9BZ81 | |
| YLSWYQQKPGQAPRL | 56 | A0A0C4DH55 | |
| LINPNFYGYQDAPWK | 2676 | Q9UKN7 | |
| QGLKAYSNWPTYPQL | 291 | O76003 | |
| PQGAVSVPWCYYSKN | 121 | O43451 | |
| NYLDWYLQKPGQSPQ | 56 | P01615 | |
| ALWIYPTNCPVRDYQ | 81 | Q8IYD8 | |
| DLIQCYNFGWYPESP | 251 | P05160 | |
| NYVSWYQQLPGTAPK | 51 | P01701 | |
| VKGNWYPYNGQCLPD | 341 | Q5GLZ8 | |
| PCQWNYRPDHCIYGS | 336 | Q4G148 | |
| PQDYPSHQNCEWIVY | 46 | O60462 | |
| CQAFAADPKPYWNQA | 81 | Q9BYJ0 | |
| AWPLNYPPGTNCSWY | 61 | O75074 | |
| TYQVKGYCLPWEQPC | 361 | O75074 | |
| QGIYLNWSPEAYCLV | 1736 | Q5S007 | |
| PYCGPNWIQHYLCDA | 166 | Q8NGN5 | |
| CKYQTPDHWYPSDLQ | 76 | P0CG30 | |
| GCNWIQQYSFGPEKY | 176 | Q9NUU6 | |
| DFGVSWNYLVPQCLP | 2781 | P78509 | |
| QYWPEKTSGCYGPIQ | 1286 | O14522 | |
| WPCLQYWPEPGRQQY | 1286 | Q92729 | |
| INGYPRPNVYWINKT | 161 | O75144 | |
| NPLYYNLCDRSGAWG | 36 | Q9NQ84 | |
| LQWPNEVPGYFQFLC | 91 | Q86SP6 | |
| GFPNRYPPNKECIWY | 1406 | O60494 | |
| PKYPETYPSNLNCSW | 2106 | O60494 | |
| YPNNTYCEWVLVAPA | 3531 | O60494 | |
| LQCKPFSWYLENIYP | 406 | Q10472 | |
| VYDPCNLAQYPGWPL | 231 | O95352 | |
| NWANRLYVPYEQGAP | 176 | P54108 | |
| SQAQKNYPYSPRWDG | 341 | Q9NXR7 | |
| GTILPNNYPCYVTGW | 146 | P08218 | |
| SRYNAYCCPGWKTLP | 61 | P35555 | |
| TQNYREWVLEPYCPS | 181 | A6NCJ1 | |
| SWYSPSQCYLQLQPP | 446 | Q8IZJ3 | |
| CKYQTPDHWYPSDLQ | 76 | P0CG29 | |
| GLDNPYANLCTWLPQ | 3311 | Q8WXX0 | |
| PQKVYLPWSRVEYQC | 226 | Q92496 | |
| PWYCNYVQICAPNGR | 81 | O75342 | |
| NYWRNVIPDPSKYCG | 166 | P20933 | |
| NYLDWYLQKPGQSPQ | 56 | A0A075B6P5 | |
| SYLAWYQQKPGQAPR | 51 | P04433 | |
| SSYLAWYQQKPGQAP | 51 | P01619 | |
| YTKNRNFCLPGVPWN | 141 | Q53GD3 | |
| VETYVKYQPCAWGQP | 76 | Q9Y6C2 | |
| YPARPSARNKNWCAY | 36 | Q9BXX0 | |
| GECYPVYWNQADKIP | 271 | Q8NEL9 | |
| SYPAYYPNNAKCVWE | 1781 | Q9UGM3 | |
| WNGYYECRPQITPNL | 2156 | Q9UGM3 | |
| PFLWYLYCEPSQLQE | 176 | Q5VW36 | |
| YICWFQPYQGKNPNT | 306 | Q8N328 | |
| GTWDGLKCQCPNLYY | 4151 | Q685J3 | |
| QPYPLVWGHYDLCKT | 21 | Q9Y2I2 | |
| CLPTHYWRQGCYPNV | 441 | Q96CW9 | |
| KSYQPWGNVPDANYT | 426 | Q9BYT3 | |
| NADVGYYSWRCPKPL | 111 | Q9Y365 | |
| QPEVGLIHQYCQGYW | 736 | Q13275 | |
| YNAQPVGNWSDCILP | 961 | Q9UPZ6 | |
| PVKPCYRWQYGQWSP | 1336 | Q9UPZ6 | |
| INIQWQKYCYPLIGS | 391 | Q6UWF7 | |
| FLGLQPYGRQPTWCY | 1196 | Q8NE09 | |
| LCHLYYNWPGIVSVP | 806 | Q7Z3Z4 | |
| YNWPGIVSVPAPCQY | 811 | Q7Z3Z4 | |
| VQRCDRNYWYFTPPN | 801 | O43147 | |
| IPSGPWQEAKCSYPY | 291 | Q8IZD0 | |
| FCVTVNPYKWLPVYN | 121 | P13533 | |
| AAKLQQYYCWPTGGA | 586 | P35712 | |
| LGYCPQENALWPNLT | 1361 | O94911 | |
| GPWQSNLAPSQLEYY | 511 | Q9Y2G3 | |
| VPYRGNTYNIPICLW | 61 | Q99816 | |
| WLPYYSAPNKCELNC | 106 | O95428 | |
| YPGHYPPNIDCTWNI | 356 | Q9Y5Y6 | |
| VYAGWCISLYNPNLP | 1626 | Q5T1R4 | |
| QPGQKVYVWYGGQEC | 76 | Q9H8N7 | |
| IFCGQIWPVDQQLYY | 206 | Q8NFJ6 | |
| NFNPLPYWNAGCQLV | 666 | Q4KWH8 | |
| QKQDVLLLYYAPWCG | 706 | Q6PKC3 | |
| NYNPDNPKERGFWYD | 226 | Q96T88 | |
| NPVSIPGQRYSWYLC | 181 | Q2M2D7 | |
| YLVCNYAPKGNWIGE | 206 | O43692 | |
| TYWNELPQSACNPTY | 2631 | Q9BXT5 | |
| FISQPYGNWSDCILP | 926 | Q9C0I4 | |
| YCPPAWGLSQQDYLQ | 431 | Q6UX68 | |
| IYQPGQLPSEQYWNK | 206 | Q9UN76 | |
| YPRSIAQYWLGCPAP | 461 | P04004 | |
| VLEGGYENWLLCYPQ | 296 | P40818 | |
| LCGYNQKLYPCWETQ | 476 | Q7Z402 | |
| PYTCLPVWAGFRIYN | 176 | Q9BZW5 | |
| GPCPPRHYTQFWNYL | 71 | O95407 | |
| YNIFPRTWCLPADYG | 171 | A6NNM8 | |
| LQGPCKAYAPRWAYN | 391 | Q8TEU8 | |
| YGASSPWCDYQLRPN | 1366 | P35573 | |
| YFQPPGTWIQCALES | 61 | Q96D46 |